Enliven Therapeutics, Inc. (NASDAQ:ELVN) Short Interest Down 26.3% in March
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) was the target of a large decrease in short interest in March. As of March 31st, there was short interest totaling 6,053,456 shares, a decrease of 26.3% from the March 15th total of 8,215,500 shares. Based on an average daily trading volume, of 2,117,376 shares, the days-to-cover […]
15 Apr 19:56 · The Cerbat Gem